Finerenone in Asian Patients with Type 2 Diabetes Mellitus and Albuminuric Chronic Kidney Disease: From Evidence to Implementation.

Yamanouchi M, Furuichi K, Wada T

Open source

DOI
10.4093/dmj.2026.0306
Published
2026 Jul
Container
Diabetes & metabolism journal
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.4093/dmj.2026.0306,
  title = {Finerenone in Asian Patients with Type 2 Diabetes Mellitus and Albuminuric Chronic Kidney Disease: From Evidence to Implementation.},
  author = {Yamanouchi M and Furuichi K and Wada T},
  year = {2026},
  journal = {Diabetes \& metabolism journal},
  doi = {10.4093/dmj.2026.0306},
  url = {https://doi.org/10.4093/dmj.2026.0306}
}

RIS

TY  - JOUR
TI  - Finerenone in Asian Patients with Type 2 Diabetes Mellitus and Albuminuric Chronic Kidney Disease: From Evidence to Implementation.
AU  - Yamanouchi M
AU  - Furuichi K
AU  - Wada T
PY  - 2026
JO  - Diabetes & metabolism journal
DO  - 10.4093/dmj.2026.0306
UR  - https://doi.org/10.4093/dmj.2026.0306
ER  - 

APA

M, Y., K, F., & T, W. (2026). Finerenone in Asian Patients with Type 2 Diabetes Mellitus and Albuminuric Chronic Kidney Disease: From Evidence to Implementation.. Diabetes & metabolism journal. https://doi.org/10.4093/dmj.2026.0306

Source records